RAPID AND SUSTAINED IMPROVEMENT IN SLEEP QUALITY, ANXIETY, AND DEPRESSION IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB TREATMENT

被引：0
|
作者：
Merola, Joseph F. [1 ]
Chiou, Albert S. [2 ]
During, Emmanuel [2 ]
Foley, Peter [3 ]
Ardeleanu, Marius [4 ]
Wu, Jiangming [5 ]
Ozturk, Zafer E. [6 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Stanford Univ, Palo Alto, CA USA
[3] Skin Hlth Inst, Carlton, Vic, Australia
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Bridgewater, NJ USA
[6] Sanofi, Cambridge, MA USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P8.23
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [21] Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series
    Votto, Martina
    Delle Cave, Francesco
    De Filippo, Maria
    Marseglia, Alessia
    Marseglia, Gian Luigi
    Brazzelli, Valeria
    Licari, Amelia
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 31 - 33
  • [22] Dupilumab provides sustained improvement of sleep disturbance in children ≥6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A. S.
    Wollenberg, A.
    Simpson, E. L.
    Beck, L. A.
    Chih-ho, Hong H.
    Marcoux, D.
    Bastian, M.
    Chen, Z.
    Levit, N. A.
    Bansal, A.
    Rossi, A. B.
    Chao, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 97 - 98
  • [23] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    Marjolein S. de Bruin-Weller
    Esther Serra-Baldrich
    Sebastien Barbarot
    Susanne Grond
    Christopher Schuster
    Helmut Petto
    Jean-Philippe Capron
    Afaf Raibouaa
    Thomas Werfel
    Dermatology and Therapy, 2022, 12 : 1481 - 1491
  • [24] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    de Bruin-Weller, Marjolein S.
    Serra-Baldrich, Esther
    Barbarot, Sebastien
    Grond, Susanne
    Schuster, Christopher
    Petto, Helmut
    Capron, Jean-Philippe
    Raibouaa, Afaf
    Werfel, Thomas
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1481 - 1491
  • [25] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [26] Sleep is significantly improved by dupilumab in adults with moderate-to-severe atopic dermatitis: results of the DUPISTAD study
    Merola, J. F.
    Chiou, A. S.
    During, E.
    Costanzo, A.
    Foley, P.
    Ardeleanu, M.
    Liu, M.
    Ozturk, Z. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E156 - E156
  • [27] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
  • [28] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [29] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [30] Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials
    Barbarot, S.
    Wollenberg, A.
    Silverberg, J., I
    Deleuran, M.
    Pellacani, G.
    Armario-Hita, J. C.
    Cheng, Z.
    Shumel, B.
    Eckert, L.
    Gadkari, A.
    Lu, Y.
    Rossi, A. B.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 266 - 277
12345